Last reviewed · How we verify
NCT04256876: TaPaS
TTNS Versus Sham Therapy for Children With iOAB (TaPaS Part I)
NA trial testing TTNS in Overactive Bladder Syndrome in 6 participants. Terminated before completion.
1 July 2020
Quick facts
| Lead sponsor | University Hospital, Ghent |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 6 |
| Start date | 7 November 2018 |
| Primary completion | 1 July 2020 |
| Estimated completion | 1 July 2020 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- TTNS
- TTNS Sham
Conditions studied
- Overactive Bladder Syndrome — all drugs for Overactive Bladder Syndrome →
Sponsor
University Hospital, Ghent
Who can join
Adults 5 to 12, any sex, with Overactive Bladder Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Part I of the TaPaS trial forms part of a twofold clinical RCT: Part 1) A prospective RCT comparing the efficacy of transcutaneous tibial nerve stimulation (TTNS) with TTNS sham therapy for children with idiopathic overactive bladder on clinical and patient reported outcomes (PROMS). Part 2) A prospective RCT comparing TTNS versus Percutaneous tibial nerve stimulation (PTNS) on clinical outcomes and PROMS.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofol
Ghijselings L, Renson C, Van de Walle J, Everaert K, et al · · 2021 · cited 5× · PMID 33810804 · DOI 10.1186/s13063-021-05117-8 -
Clinical efficacy of Transcutaneous Tibial Nerve Stimulation (TTNS) versus Sham therapy (Part I) and TTNS versus Percutaneous Tibial Nerve Stimulation (PTNS) (Part II) on the short term in children with the idiopathic overactive bladder syndrome: Protocol for Part I of the two-fo
Ghijselings L, Renson C, Walle JV, Everaert K, et al · · 2021 · DOI 10.21203/rs.3.rs-35470/v2
Verify or expand the search:
- PubMed search for NCT04256876
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of TTNS
Trials testing the same drug.
- NCT04284020 — Educational Program Plus Physiotherapy After Prostatectomy · NA · unknown
- NCT03250650 — Physiotherapy in Overactive Bladder: Electrical Stimulation Treatment · NA · completed
Other recruiting trials for Overactive Bladder Syndrome
Currently open trials in the same condition.
- NCT05895045 — Yoga for Treatment of Overactive Bladder in Pediatric Patients · NA · recruiting
- NCT07081412 — Home-Based Transcutaneous Remotely Monitored Posterior Tibial Neuromodulation · NA · recruiting
- NCT07184307 — Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial · NA · recruiting
- NCT06546189 — Oral Lactobacillus Supplementation as Treatment for Overactive Bladder Syndrome: A Randomised Controlled Trial · NA · recruiting
- NCT06351683 — Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome · Phase 2 · recruiting
Other University Hospital, Ghent trials
Trials by the same sponsor.
- NCT07584486 — Development of a New Simplified Tool to Predict LNPCPs Histology and Assess the Risk of Submucosal Invasive Cancer. The · NA · not yet recruiting
- NCT07327450 — Coaching Doctors and Nurses to Improve Ethical Decision-making in Team · NA · not yet recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07387328 — Validation of New sEMG Electrode Placement Guidelines for the Triceps Surae in Post-stroke Individuals. · not yet recruiting
- NCT07237399 — Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04256876 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Ghent
- Last refreshed: 4 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04256876.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing